TDOC - Teladoc Health Inc Stock Price, Fair Value and News

12.35USD+0.15 (+1.23%)Delayed as of 09 May 2024, 12:12 pm ET

Market Summary

USD12.35+0.15

Delayedas of 09 May 2024, 12:12 pm

1.23%

TDOC Alerts

1 major insider sales recently.

Losses in recent quarter

TDOC Stock Price

View Fullscreen

TDOC RSI Chart

TDOC Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

-8.88

Price/Sales (Trailing)

0.79

EV/EBITDA

-12.09

Price/Free Cashflow

6.17

TDOC Price/Sales (Trailing)

TDOC Profitability

Operating Margin

95.09%

EBT Margin

-8.79%

Return on Equity

-10.18%

Return on Assets

-5.39%

Free Cashflow Yield

16.22%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

2.68%

Rev. Growth (Qtr)

-2.18%

TDOC Earnings

Earnings (TTM)

-233.0M

Earnings Growth (Yr)

-18.29%

Earnings Growth (Qtr)

-183.45%

Breaking Down TDOC Revenue

52 Week Range

12.35

(Low)(High)

Last 7 days

-4.8%

Last 30 days

-16.5%

Last 90 days

-40.1%

Trailing 12 Months

-51.3%

How does TDOC drawdown profile look like?

TDOC Financial Health

Current Ratio

3.82

Debt/Equity

0.67

Debt/Cashflow

0.22

TDOC Investor Care

Shares Dilution (1Y)

3.62%

Diluted EPS (TTM)

-1.41

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.6B	0	0	0
2023	2.5B	2.5B	2.6B	2.6B
2022	2.1B	2.2B	2.3B	2.4B
2021	1.4B	1.6B	1.9B	2.0B
2020	605.5M	716.3M	867.1M	1.1B
2019	456.8M	492.6M	519.6M	553.3M
2018	280.0M	330.0M	372.3M	417.9M
2017	139.2M	157.3M	193.5M	233.3M
2016	87.8M	96.0M	108.4M	123.2M
2015	50.6M	58.6M	67.7M	77.4M
2014	0	27.8M	35.7M	43.5M
2013	0	0	0	19.9M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Teladoc Health Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	raman-tangella vidya	sold	-46,831	12.688	-3,691	chief medical officer
May 02, 2024	waters michael willem	sold	-73,501	12.688	-5,793	chief operating officer
May 02, 2024	kornwasser laizer	sold	-132,095	12.688	-10,411	president, enterprise growth
May 01, 2024	raman-tangella vidya	acquired	-	-	10,244	chief medical officer
May 01, 2024	kornwasser laizer	acquired	-	-	20,198	president, enterprise growth
May 01, 2024	waters michael willem	acquired	-	-	11,319	chief operating officer
Apr 17, 2024	trencher daniel	sold	-13,210	13.21	-1,000	chief strategy officer
Apr 02, 2024	nanis nikolaos p.	sold	-6,598	14.314	-461	chief technology officer
Apr 01, 2024	nanis nikolaos p.	acquired	-	-	1,232	chief technology officer
Mar 25, 2024	geshuri arnnon	sold	-112,950	15.06	-7,500	chief people officer

Which funds bought or sold TDOC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Cornerstone Planning Group LLC	unchanged	-	-771	1,125	-%
May 07, 2024	Strengthening Families & Communities, LLC	reduced	-67.37	-25,553	8,000	-%
May 07, 2024	Quantum Private Wealth, LLC	reduced	-1.72	-279,370	617,908	0.23%
May 07, 2024	O'Dell Group, LLC	sold off	-100	-1,940	-	-%
May 07, 2024	MONTAG A & ASSOCIATES INC	unchanged	-	-37,113	86,886	-%
May 07, 2024	AllSquare Wealth Management LLC	sold off	-100	-5,107	-	-%
May 07, 2024	M&T Bank Corp	sold off	-100	-240,733	-	-%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	reduced	-49.32	-87,280	94,360	-%
May 07, 2024	Arizona State Retirement System	reduced	-1.33	-306,679	687,035	-%
May 07, 2024	RIVER GLOBAL INVESTORS LLP	sold off	-100	-158,580	-	-%

Are Funds Buying or Selling TDOC?

Are funds buying TDOC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TDOC

No. of Funds

Unveiling Teladoc Health Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	nikko asset management americas, inc.	4.50%	7,464,874	SC 13G/A
Feb 13, 2024	vanguard group inc	10.58%	17,514,904	SC 13G/A
Feb 05, 2024	sumitomo mitsui trust holdings, inc.	4.51%	7,474,674	SC 13G/A
Jan 29, 2024	ark investment management llc	12.82%	21,224,565	SC 13G/A
Jan 26, 2024	blackrock inc.	8.0%	13,203,121	SC 13G/A
Jul 10, 2023	vanguard group inc	10.58%	17,313,528	SC 13G/A
Feb 10, 2023	nikko asset management americas, inc.	5.01%	8,125,231	SC 13G/A
Feb 10, 2023	ark investment management llc	11.69%	18,928,440	SC 13G/A
Feb 09, 2023	vanguard group inc	8.94%	14,476,155	SC 13G/A
Feb 07, 2023	blackrock inc.	6.2%	9,961,219	SC 13G/A

Recent SEC filings of Teladoc Health Inc

View All Filings

Date Filed	Form Type	Document
May 06, 2024	3	Insider Trading
May 02, 2024	144	Notice of Insider Sale Intent
May 02, 2024	144	Notice of Insider Sale Intent
May 02, 2024	144	Notice of Insider Sale Intent
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
Apr 29, 2024	144	Notice of Insider Sale Intent
Apr 26, 2024	10-Q	Quarterly Report
Apr 25, 2024	8-K	Current Report

Peers (Alternatives to Teladoc Health Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	10.35%	2.61%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-2.97%	32.18%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-5.69%	12.88%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-26.25%	-21.54%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	3.95%	12.19%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	1.61%	34.91%	14.61	0.97	5.77%	58.74%
UHS	11.4B	14.7B	-1.27%	18.38%	13.95	0.78	7.99%	19.23%
MID-CAP
CHE	8.7B	2.3B	-8.25%	4.64%	30.56	3.78	5.96%	18.29%
ACHC	6.1B	3.0B	-12.48%	-3.87%	-542.41	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.67%	-35.23%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.72%	19.70%	34.78	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.8B	1.1B	5.80%	29.14%	26.7	1.61	11.45%	30.74%
BKD	1.4B	3.0B	1.30%	77.47%	-7.76	0.44	4.98%	4.88%
BEAT	55.0M	-	-4.65%	-8.89%	-3.76	-	-	-12.94%
AMS	19.3M	21.3M	3.37%	9.25%	36.22	0.91	8.00%	-62.25%

Teladoc Health Inc News

Latest updates

Teladoc Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.2%	646,131,000	660,527,000	660,238,000	652,406,000	629,244,000	637,709,000	611,402,000	592,379,000	565,350,000	554,235,000	521,658,000	503,139,000	453,675,000	383,321,000	288,812,000	241,030,000	180,799,000	156,489,000	137,969,000	130,276,000	128,573,000
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83,896,000
Costs and Expenses	5.4%	733,253,000	695,608,000	724,963,000	724,051,000	706,346,000	4,453,262,000	683,132,000	3,688,931,000	7,234,729,000	595,664,000	582,234,000	582,087,000	538,353,000	841,827,000	308,537,000	248,209,000	201,810,000	172,077,000	157,913,000	152,299,000	151,460,000
S&GA Expenses	1.7%	54,364,000	53,451,000	52,309,000	53,530,000	54,490,000	56,279,000	54,634,000	57,930,000	58,329,000	59,330,000	62,602,000	63,856,000	64,793,000	93,942,000	23,483,000	18,687,000	17,940,000	16,751,000	16,120,000	15,832,000	16,212,000
R&D Expenses	-9.5%	81,388,000	89,938,000	84,289,000	87,309,000	86,985,000	82,931,000	84,590,000	78,696,000	87,412,000	72,867,000	80,250,000	80,759,000	78,008,000	92,697,000	29,958,000	23,029,000	19,257,000	16,246,000	15,746,000	16,665,000	15,987,000
EBITDA Margin	-3.7%	-0.08	-0.08	-1.42	-1.47	-2.74	-5.56	-4.10	-4.29	-3.09	-0.05	-0.37	-0.42	-	-	-	-	-	-	-	-	-
Interest Expenses	2.0%	5,649,000	5,538,000	5,646,000	5,835,000	5,263,000	10,151,000	6,149,000	5,562,000	-5,480,000	142,634,000	-18,895,000	-20,473,000	-22,125,000	-21,100,500	-16,970,000	-13,262,000	-8,618,000	-7,581,000	-7,700,000	-7,211,000	-6,521,000
Income Taxes	-23.5%	2,690,000	3,515,000	-2,484,000	-952,000	681,000	-1,841,000	-1,171,000	-1,188,000	388,000	-49,734,500	3,643,000	3,200,000	87,000,000	-85,457,500	-2,300,000	-2,399,000	-700,000	-4,125,000	-7,300,000	100,000	742,000
Earnings Before Taxes	-212.1%	-79,199,000	-25,375,000	-59,557,000	-66,129,000	-68,547,000	-3,811,912,000	-74,647,000	-3,102,649,000	-6,674,135,000	-60,726,000	-80,697,000	-130,623,000	-112,610,000	-479,424,000	-38,174,000	-28,081,000	-30,314,000	-23,169,000	-27,644,000	-29,234,000	-29,408,000
EBT Margin	-4.2%	-0.09	-0.08	-1.55	-1.59	-2.86	-5.68	-4.27	-4.44	-3.24	-0.19	-0.43	-0.47	-	-	-	-	-	-	-	-	-
Net Income	-183.5%	-81,889,000	-28,890,000	-57,073,000	-65,177,000	-69,228,000	-3,810,071,000	-73,476,000	-3,101,461,000	-6,674,523,000	-10,985,000	-84,340,000	-133,819,000	-199,649,000	-393,967,000	-35,884,000	-25,682,000	-29,603,000	-19,044,000	-20,346,000	-29,324,000	-30,150,000
Net Income Margin	-5.1%	-0.09	-0.08	-1.55	-1.59	-2.86	-5.68	-4.24	-4.42	-3.22	-0.21	-0.44	-0.47	-	-	-	-	-	-	-	-	-
Free Cashflow	-94.0%	7,771,000	128,678,000	99,808,000	99,278,000	10,793,000	59,354,000	59,191,000	89,927,000	-35,660,000	80,285,000	75,385,000	49,927,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.6%	4,321	4,392	4,328	4,316	4,309	4,345	8,104	8,103	11,092	17,735	17,653	17,611	17,582	17,755	3,449	2,419	1,603	1,603	1,568	1,565	1,552
Current Assets	-0.2%	1,486	1,489	1,387	1,321	1,287	1,315	1,288	1,257	1,208	1,225	1,157	1,105	1,032	1,060	1,310	1,403	596	588	558	533	541
Cash Equivalents	-2.3%	1,098	1,124	1,031	959	889	918	900	881	836	893	824	784	720	733	1,187	1,309	508	514	475	440	434
Inventory	9.3%	32.00	30.00	36.00	34.00	46.00	56.00	59.00	60.00	71.00	73.00	57.00	57.00	58.00	56.00	12.00	-	-	-	-	-	-
Net PPE	-7.7%	30.00	32.00	33.00	30.00	30.00	30.00	27.00	27.00	28.00	27.00	27.00	28.00	28.00	29.00	20.00	10.00	10.00	10.00	10.00	10.00	10.00
Goodwill	0%	1,073	1,073	1,073	1,073	1,073	1,073	4,846	4,858	7,900	14,504	14,470	14,455	14,452	14,581	1,691	900	734	746	738	748	734
Current Liabilities	-7.6%	389	421	403	383	381	400	411	371	307	331	302	276	260	333	201	124	97.00	90.00	85.00	70.00	72.00
Long Term Debt	0.1%	1,540	1,539	1,538	1,537	1,536	1,535	1,534	1,534	1,533	1,226	1,211	1,201	1,353	1,380	953	948	447	440	434	427	421
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.00	-	-	-	-	-	-	-
LT Debt, Non Current	0.1%	1,540	1,539	1,538	1,537	1,536	1,535	1,534	1,534	1,533	1,226	1,211	1,201	1,353	1,380	953	948	447	440	434	427	421
Shareholder's Equity	-1.6%	2,289	2,326	2,294	2,295	2,291	2,308	6,053	6,085	9,143	16,046	15,988	16,001	15,829	15,884	2,231	1,295	1,000	1,014	994	1,003	1,002
Retained Earnings	-0.5%	-15,310	-15,228	-15,199	-15,142	-15,077	-15,008	-11,198	-11,124	-8,023	-1,421	-1,410	-1,326	-1,192	-992	-598	-562	-537	-507	-488	-468	-438
Additional Paid-In Capital	0.3%	17,638	17,592	17,535	17,476	17,410	17,359	17,300	17,239	17,177	17,473	17,399	17,315	17,017	16,858	2,835	1,880	1,572	1,539	1,510	1,483	1,457
Shares Outstanding	1.6%	169	167	166	165	163	163	162	161	161	157	156	154	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	4,145	-	-	-	5,334	-	-	-	26,317	-	-	-	14,937	-	-	-	4,607	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-93.1%	8,920	130,082	105,601	101,182	13,156	65,549	63,021	92,469	-31,747	83,208	76,591	52,217	-18,026	-114,936	32,195	35,550	-6,320	18,122	13,490	6,149	-7,892
Share Based Compensation	-9.6%	42,325	46,823	52,964	55,725	46,038	50,754	55,662	51,000	60,436	61,615	71,701	82,970	86,300	414,380	20,908	21,928	18,315	18,457	17,354	17,368	13,523
Cashflow From Investing	2.7%	-35,512	-36,506	-37,647	-36,570	-45,624	-53,891	-41,448	-44,837	-27,567	-20,075	-34,708	-2,168	-16,030	-413,925	-155,460	-9,662	-11,928	9,547	13,194	-5,064	7,336
Cashflow From Financing	198.6%	1,751	-1,775	5,068	4,208	3,353	4,381	634	-1,334	2,816	6,625	784	11,363	22,175	70,436	422	773,225	15,053	10,041	9,153	5,198	10,702

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

TDOC Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 646,131	$ 629,244
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)	194,538	190,107
Operating expenses:
Advertising and marketing	183,329	176,790
Sales	54,364	54,490
Technology and development	81,388	86,985
General and administrative	111,697	114,145
Acquisition, integration, and transformation costs	373	5,944
Restructuring costs	9,673	8,102
Amortization of intangible assets	95,057	66,860
Depreciation of property and equipment	2,834	2,923
Total expenses	733,253	706,346
Loss from operations	(87,122)	(77,102)
Interest income	(13,942)	(8,911)
Interest expense	5,649	5,263
Other expense (income), net	370	(4,907)
Loss before provision for income taxes	(79,199)	(68,547)
Provision for income taxes	2,690	681
Net loss	(81,889)	(69,228)
Other comprehensive loss, net of tax:
Currency translation adjustment	(1,639)	1,779
Comprehensive loss	$ (83,528)	$ (67,449)
Net loss per share, basic (in dollars per share)	$ (0.49)	$ (0.42)
Net loss per share, diluted (in dollars per share)	$ (0.49)	$ (0.42)
Weighted-average shares used to compute basic net loss per share (in shares)	167,730,746	162,922,691
Weighted-average shares used to compute diluted net loss per share (in shares)	167,730,746	162,922,691

TDOC Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,097,935	$ 1,123,675
Accounts receivable, net of allowance for doubtful accounts of $3,530 and $4,240 at March 31, 2024 and December 31, 2023, respectively	214,293	217,423
Inventories	32,268	29,513
Prepaid expenses and other current assets	141,769	118,437
Total current assets	1,486,265	1,489,048
Property and equipment, net	29,550	32,032
Goodwill	1,073,190	1,073,190
Intangible assets, net	1,614,238	1,677,781
Operating lease - right-of-use assets	37,506	40,060
Other assets	80,007	80,258
Total assets	4,320,756	4,392,369
Current liabilities:
Accounts payable	37,674	43,637
Accrued expenses and other current liabilities	199,418	178,634
Accrued compensation	50,523	102,686
Deferred revenue-current	101,229	95,659
Total current liabilities	388,844	420,616
Other liabilities	1,023	1,080
Operating lease liabilities, net of current portion	39,971	42,837
Deferred revenue, net of current portion	15,002	13,623
Deferred taxes, net	47,472	49,452
Convertible senior notes, net	1,539,546	1,538,688
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.001 par value; 300,000,000 shares authorized; 169,314,029 shares and 166,658,253 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	169	167
Additional paid-in capital	17,637,902	17,591,551
Accumulated deficit	(15,310,544)	(15,228,655)
Accumulated other comprehensive loss	(38,629)	(36,990)
Total stockholders’ equity	2,288,898	2,326,073
Total liabilities and stockholders’ equity	$ 4,320,756	$ 4,392,369

About Teladoc Health Inc

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

CEO	Mr. Jason Nathanial Gorevic
WEBSITE	teladochealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	4816

Teladoc Health Inc Frequently Asked Questions

What is the ticker symbol for Teladoc Health Inc? What does TDOC stand for in stocks?

TDOC is the stock ticker symbol of Teladoc Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Teladoc Health Inc (TDOC)?

As of Wed May 08 2024, market cap of Teladoc Health Inc is 2.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers. The fair value of Teladoc Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Teladoc Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TDOC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Teladoc Health Inc a good stock to buy?

The fair value guage provides a quick view whether TDOC is over valued or under valued. Whether Teladoc Health Inc is cheap or expensive depends on the assumptions which impact Teladoc Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TDOC.

What is Teladoc Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, TDOC's PE ratio (Price to Earnings) is -8.88 and Price to Sales (PS) ratio is 0.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TDOC PE ratio will change depending on the future growth rate expectations of investors.